1283228

Kent A. Swaine, MD — FEI 3031441760

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance